LVM Capital Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-23,000
| Closed | -$252K | – | 147 |
|
|
2023
Q2 | $252K | Hold |
23,000
| – | – | 0.03% | 126 |
|
|
2023
Q1 | $201K | Buy |
23,000
+13,000
| +130% | +$114K | 0.03% | 135 |
|
|
2022
Q4 | $63K | Hold |
10,000
| – | – | 0.01% | 132 |
|
|
2022
Q3 | $35K | Hold |
10,000
| – | – | 0.01% | 130 |
|
|
2022
Q2 | $30K | Buy |
+10,000
| New | +$30K | ﹤0.01% | 129 |
|
|
2021
Q4 | – | Sell |
-15,000
| Closed | -$55K | – | 134 |
|
|
2021
Q3 | $55K | Hold |
15,000
| – | – | 0.01% | 125 |
|
|
2021
Q2 | $65K | Hold |
15,000
| – | – | 0.01% | 126 |
|
|
2021
Q1 | $68K | Sell |
15,000
-1,000
| -6% | -$4.53K | 0.01% | 124 |
|
|
2020
Q4 | $92K | Hold |
16,000
| – | – | 0.02% | 120 |
|
|
2020
Q3 | $116K | Hold |
16,000
| – | – | 0.02% | 104 |
|
|
2020
Q2 | $56K | Hold |
16,000
| – | – | 0.01% | 103 |
|
|
2020
Q1 | $24K | Hold |
16,000
| – | – | 0.01% | 100 |
|
|
2019
Q4 | $31K | Hold |
16,000
| – | – | 0.01% | 116 |
|
|
2019
Q3 | $82K | Hold |
16,000
| – | – | 0.02% | 113 |
|
|
2019
Q2 | $115K | Hold |
16,000
| – | – | 0.03% | 107 |
|
|
2019
Q1 | $212K | Sell |
16,000
-10,000
| -38% | -$133K | 0.05% | 106 |
|
|
2018
Q4 | $205K | Hold |
26,000
| – | – | 0.05% | 101 |
|
|
2018
Q3 | $288K | Hold |
26,000
| – | – | 0.07% | 99 |
|
|
2018
Q2 | $349K | Buy |
26,000
+5,000
| +24% | +$67.1K | 0.08% | 84 |
|
|
2018
Q1 | $273K | Hold |
21,000
| – | – | 0.06% | 100 |
|
|
2017
Q4 | $193K | Hold |
21,000
| – | – | 0.04% | 112 |
|
|
2017
Q3 | $169K | Buy |
21,000
+1,000
| +5% | +$8.05K | 0.04% | 113 |
|
|
2017
Q2 | $115K | Buy |
20,000
+10,000
| +100% | +$57.5K | 0.03% | 114 |
|
|
2017
Q1 | $43K | Buy |
+10,000
| New | +$43K | 0.01% | 114 |
|